MPG.eBooks - Search Results

Cover Image

41

CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

42

CADTH Canadian drug expert committee recommendation: Burosumab (Crysvita -- Kyowa Kirin Limited) : indication : treatment of x-linked hypophosphatemia

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

43

Clinical review report: Brolucizumab (Beovu) (Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular degeneration (AMD)

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

44

CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

45

Human growth hormone treatment for adult growth hormone deficiency : a review of the clinical effectiveness, safety, cost-effectiveness, and guidelines

Published 2015

CADTH Rapid Response Service

Cover Image

46

CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

47

Long-term use of ranibizumab for the treatment of age-related macular degeneration : a review of the clinical and cost-effectiveness and guidelines

Published 2014

Canadian Agency for Drugs and Technologies in Health

Cover Image

48

CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis

Published 2018

CADTH

Cover Image

49

CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: ankylosing spondylitis

Published 2020

CADTH

Cover Image

50

HPV testing for primary cervical cancer screening : a health technology assessment

by Chao, Yi-Sheng
Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

51

CADTH Canadian Drug Expert Committee recommendation: Eculizumab (Soliris - Alexion Pharma Canada Corp.) : indication : the treatment of neuromyelitis optica spectrum disorder (NMOS...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

52

Clinical and economic review report: Vedolizumab (ENTYVIO SC) Takeda Canada Inc. : indication: Crohn disease

Published 2021

Canadian Agency for Drugs and Technologies in Health

Cover Image

53

Non-invasive methods for diagnosis and monitoring of liver fibrosis in patients with chronic hepatitis B and C : a review of diagnostic accuracy, clinical effectiveness, cost-effec...

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

54

Clinical review report: Burosumab (Crysvita) (Kyowa Kirin limited) : indication: for the treatment of x-linked hypophosphatemia in adult and pediatric patients one year of age and...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

55

CADTH Canadian Drug Expert Committee recommendation: Eculizumab (Soliris -- Alexion Pharma Canada Corp.) : indication : adult patients with refractory generalized myasthenia gravis

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

56

Clinical review report: Eculizumab (Soliris) : Alexion Pharma Canada corporation : indication : adult patients with generalized myasthenia gravis

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

57

Pharmacoeconomic report: Ofatumumab (Kesimpta) (Novartis Pharmaceuticals Canada Inc.) : indication: multiple sclerosis, relapsing-remitting

Published 2021

Canadian Agency for Drugs and Technologies in Health

Cover Image

58

Clinical review report: Ofatumumab (Kesimpta) (Novartis Pharmaceuticals Canada Inc.) : indication: multiple sclerosis, relapsing-remitting

Published 2021

Canadian Agency for Drugs and Technologies in Health

Cover Image

59

Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

60

HPV testing for primary cervical cancer screening : recommendations report

Published 2019

CADTH

1
2
3
4
5
6